Clinical Trial Update: Phase I/II Study of Pazopanib+ Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme [Phase 1, Phase 2]

View source ↗

Summary

Phase I/II trial updating the combination of pazopanib and temozolomide for newly diagnosed glioblastoma multiforme, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Pazopanib (Votrient) (Pazopanib)
• Temozolomide (Temozolomide)

Snippet

Sponsor: Centre Antoine Lacassagne | Conditions: Glioblastoma Multiforme | Phase 1, Phase 2 | Status: RECRUITING